Tarrabain Alex 5
5 · CEN BIOTECH INC · Filed Apr 29, 2021
Insider Transaction Report
Form 5
CEN BIOTECH INCCENBF
Tarrabain Alex
DirectorChief Financial Officer
Transactions
- Other
Common Stock
2020-06-16+3,000→ 1,457,942 total - Other
Common Stock
2020-07-16+3,000→ 1,457,942 total - Other
Common Stock
2020-10-16+3,000→ 1,457,942 total - Other
Common Stock
2020-12-16+3,000→ 1,457,942 total - Other
Common Stock
2020-02-16+3,000→ 1,457,942 total - Other
Common Stock
2020-01-16+3,000→ 1,457,942 total - Other
Common Stock
2020-03-16+3,000→ 1,457,942 total - Other
Common Stock
2020-04-16+3,000→ 1,457,942 total - Other
Common Stock
2020-05-16+3,000→ 1,457,942 total - Other
Common Stock
2020-08-16+3,000→ 1,457,942 total - Other
Common Stock
2020-09-16+3,000→ 1,457,942 total - Other
Common Stock
2020-11-16+3,000→ 1,457,942 total
Footnotes (2)
- [F1]36,000 shares of common stock of the issuer were issued as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 3,000 shares on the following dates: 1/16/2020, 2/16/2020, 3/16/2020, 4/16/2020, 5/16/2020, 6/16/2020, 7/16/2020, 8/16/2020, 9/16/2020, 10/16/2020, 11/16/2020 and 12/16/2020.
- [F2]Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000.